Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Debt / NOTE 0.500% 8/1
-
Number of holders
-
71
-
Total principal
-
580M
-
Principal change
-
+20.9M
-
Total reported value, excl. options
-
$566M
-
Value change
-
+$22.6M
-
Number of buys
-
28
-
Number of sells
-
-23
-
Price
-
$0.97
Significant Holders of INTEGRA LIFESCIENCES HLDGS C - NOTE 0.500% 8/1 as of Q1 2023
70 filings reported holding 457985AM1 - INTEGRA LIFESCIENCES HLDGS C - NOTE 0.500% 8/1 as of Q1 2023.
INTEGRA LIFESCIENCES HLDGS C - NOTE 0.500% 8/1 has 71 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $580M of principal
.
Largest 10 bondholders include Invesco Ltd. ($58M of principal), HIGHBRIDGE CAPITAL MANAGEMENT LLC ($48.7M of principal), Aequim Alternative Investments LP ($35M of principal), Shaolin Capital Management LLC ($28.5M of principal), CAPSTONE INVESTMENT ADVISORS, LLC ($27M of principal), MACKAY SHIELDS LLC ($26.5M of principal), CITIGROUP INC ($24.6M of principal), AVIVA PLC ($24.6M of principal), JPMORGAN CHASE & CO ($23.4M of principal), and WELLS FARGO & COMPANY/MN ($21.7M of principal).
This table shows the top 71 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.